Corrections
Am Fam Physician. 2000 Nov 1;62(9):1967.
The article “Successful Management of the Obese Patient” (June 15, 2000, page 3615) contained an error in Table 1 (page 3618). Orlistat (Xenical) is incorrectly listed as a DEA schedule IV medication; orlistat does not have a DEA listing. The corrected table is reprinted below. An error was also made in the biography; Dr. Poston is co-director of behavioral cardiology research, not of the residency program.
Medications Labeled by the FDA for the Treatment of Obesity
| Agent | DEA schedule | Action |
|---|---|---|
Diethylpropion (Tenuate) | IV | Noradrenergic |
Mazindol (Sanorex) | IV | Noradrenergic |
Orlistat* (Xenical) | — | Lipase inhibitor |
Phendimetrazine (Plegine) | III | Noradrenergic |
Phentermine (Fastin) | IV | Noradrenergic |
Phentermine resin (Ionamin) | IV | Noradrenergic |
Phenylpropanolamine (Dexatrim) | OTC | Noradrenergic |
Sibutramine* (Meridia) | IV | SNRI |
FDA = U.S. Food and Drug Administration; DEA = Drug Enforcement Administration; OTC = over-the-counter; SNRI = serotonergic noradrenergic reuptake inhibitor.
*— Orlistat and sibutramine are the only drugs labeled by the FDA for long-term treatment of obesity.
Medications Labeled by the FDA for the Treatment of Obesity
| Agent | DEA schedule | Action |
|---|---|---|
Diethylpropion (Tenuate) | IV | Noradrenergic |
Mazindol (Sanorex) | IV | Noradrenergic |
Orlistat* (Xenical) | — | Lipase inhibitor |
Phendimetrazine (Plegine) | III | Noradrenergic |
Phentermine (Fastin) | IV | Noradrenergic |
Phentermine resin (Ionamin) | IV | Noradrenergic |
Phenylpropanolamine (Dexatrim) | OTC | Noradrenergic |
Sibutramine* (Meridia) | IV | SNRI |
FDA = U.S. Food and Drug Administration; DEA = Drug Enforcement Administration; OTC = over-the-counter; SNRI = serotonergic noradrenergic reuptake inhibitor.
*— Orlistat and sibutramine are the only drugs labeled by the FDA for long-term treatment of obesity.
Copyright © 2000 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact
afpserv@aafp.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions
More in Pubmed
MOST RECENT ISSUE
Email Alerts
Don't miss a single issue. Sign up for the free AFP email table of contents.
